Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT

NCT05468229 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Glucose Intolerance

Interventions

DRUG: Dorzagliatin
DRUG: Placebo

Sponsor

Chinese University of Hong Kong